TY - JOUR AU - Bolouri, M. S. AU - Elias, S. G. AU - Wisner, D. J. AU - Behr, S. C. AU - Hawkins, R. A. AU - Suzuki, S. A. PY - 2013 DA - 2013// TI - Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging JO - Radiology. VL - 269 UR - https://doi.org/10.1148/radiol.13130058 DO - 10.1148/radiol.13130058 ID - Bolouri2013 ER - TY - JOUR AU - Choi, B. B. AU - Kim, S. H. AU - Kang, B. J. AU - Lee, J. H. AU - Song, B. J. AU - Jeong, S. H. PY - 2012 DA - 2012// TI - Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma JO - World J Surg Oncol. VL - 10 UR - https://doi.org/10.1186/1477-7819-10-126 DO - 10.1186/1477-7819-10-126 ID - Choi2012 ER - TY - JOUR AU - Bos, R. AU - Hoeven, J. J. AU - Wall, E. AU - Groep, P. AU - Diest, P. J. AU - Comans, E. F. PY - 2002 DA - 2002// TI - Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography JO - J Clin Oncol. VL - 20 UR - https://doi.org/10.1200/JCO.20.2.379 DO - 10.1200/JCO.20.2.379 ID - Bos2002 ER - TY - JOUR AU - Koolen, B. B. AU - Vrancken Peeters, M. J. AU - Wesseling, J. AU - Lips, E. H. AU - Vogel, W. V. AU - Aukema, T. S. PY - 2012 DA - 2012// TI - Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy JO - Eur J Nucl Med Mol Imaging. VL - 39 UR - https://doi.org/10.1007/s00259-012-2211-z DO - 10.1007/s00259-012-2211-z ID - Koolen2012 ER - TY - JOUR AU - Flanagan, F. L. AU - Dehdashti, F. AU - Siegel, B. A. PY - 1998 DA - 1998// TI - PET in breast cancer JO - Semin Nucl Med. VL - 28 UR - https://doi.org/10.1016/S0001-2998(98)80034-2 DO - 10.1016/S0001-2998(98)80034-2 ID - Flanagan1998 ER - TY - JOUR AU - Ekmekcioglu, O. AU - Aliyev, A. AU - Yilmaz, S. AU - Arslan, E. AU - Kaya, R. AU - Kocael, P. PY - 2013 DA - 2013// TI - Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma JO - Nucl Med Commun. VL - 34 UR - https://doi.org/10.1097/MNM.0b013e3283658369 DO - 10.1097/MNM.0b013e3283658369 ID - Ekmekcioglu2013 ER - TY - JOUR AU - Gil-Rendo, A. AU - Martinez-Regueira, F. AU - Zornoza, G. AU - Garcia-Velloso, M. J. AU - Beorlegui, C. AU - Rodriguez-Spiteri, N. PY - 2009 DA - 2009// TI - Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer JO - Br J Surg. VL - 96 UR - https://doi.org/10.1002/bjs.6459 DO - 10.1002/bjs.6459 ID - Gil-Rendo2009 ER - TY - JOUR AU - Groheux, D. AU - Giacchetti, S. AU - Moretti, J. L. AU - Porcher, R. AU - Espie, M. AU - Lehmann-Che, J. PY - 2011 DA - 2011// TI - Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer JO - Eur J Nucl Med Mol Imaging. VL - 38 UR - https://doi.org/10.1007/s00259-010-1640-9 DO - 10.1007/s00259-010-1640-9 ID - Groheux2011 ER - TY - JOUR AU - Heudel, P. AU - Cimarelli, S. AU - Montella, A. AU - Bouteille, C. AU - Mognetti, T. PY - 2010 DA - 2010// TI - Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors JO - Int J Clin Oncol. VL - 15 UR - https://doi.org/10.1007/s10147-010-0120-3 DO - 10.1007/s10147-010-0120-3 ID - Heudel2010 ER - TY - JOUR AU - Sanli, Y. AU - Kuyumcu, S. AU - Ozkan, Z. G. AU - Isik, G. AU - Karanlik, H. AU - Guzelbey, B. PY - 2012 DA - 2012// TI - Increased FDG uptake in breast cancer is associated with prognostic factors JO - Ann Nucl Med. VL - 26 UR - https://doi.org/10.1007/s12149-012-0579-2 DO - 10.1007/s12149-012-0579-2 ID - Sanli2012 ER - TY - JOUR AU - Arps, D. P. AU - Healy, P. AU - Zhao, L. AU - Kleer, C. G. AU - Pang, J. C. PY - 2013 DA - 2013// TI - Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast JO - Breast Cancer Res Treat. VL - 138 UR - https://doi.org/10.1007/s10549-013-2493-2 DO - 10.1007/s10549-013-2493-2 ID - Arps2013 ER - TY - JOUR AU - Lim, S. T. AU - Yu, J. H. AU - Park, H. K. AU - Moon, B. I. AU - Ko, B. K. AU - Suh, Y. J. PY - 2014 DA - 2014// TI - A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population JO - World J Surg Oncol. VL - 12 UR - https://doi.org/10.1186/1477-7819-12-56 DO - 10.1186/1477-7819-12-56 ID - Lim2014 ER - TY - JOUR AU - Avril, N. AU - Rose, C. A. AU - Schelling, M. AU - Dose, J. AU - Kuhn, W. AU - Bense, S. PY - 2000 DA - 2000// TI - Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations JO - J Clin Oncol. VL - 18 ID - Avril2000 ER - TY - JOUR AU - Ueda, S. AU - Tsuda, H. AU - Asakawa, H. AU - Shigekawa, T. AU - Fukatsu, K. AU - Kondo, N. PY - 2008 DA - 2008// TI - Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer JO - Jpn J Clin Oncol. VL - 38 UR - https://doi.org/10.1093/jjco/hyn019 DO - 10.1093/jjco/hyn019 ID - Ueda2008 ER - TY - JOUR AU - Buck, A. K. AU - Schirrmeister, H. AU - Mattfeldt, T. AU - Reske, S. N. PY - 2004 DA - 2004// TI - Biological characterisation of breast cancer by means of PET JO - Eur J Nucl Med Mol Imaging. VL - 31 UR - https://doi.org/10.1007/s00259-004-1529-6 DO - 10.1007/s00259-004-1529-6 ID - Buck2004 ER - TY - JOUR AU - Gnant, M. AU - Harbeck, N. AU - Thomssen, C. PY - 2011 DA - 2011// TI - St. Gallen 2011: summary of the consensus discussion JO - Breast Care (Basel). VL - 6 UR - https://doi.org/10.1159/000328054 DO - 10.1159/000328054 ID - Gnant2011 ER - TY - JOUR AU - Kim, J. Y. AU - Kim, S. H. AU - Kim, Y. J. AU - Kang, B. J. AU - An, Y. Y. AU - Lee, A. W. PY - 2015 DA - 2015// TI - Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers? JO - Magn Reson Imaging. VL - 33 UR - https://doi.org/10.1016/j.mri.2014.08.034 DO - 10.1016/j.mri.2014.08.034 ID - Kim2015 ER - TY - JOUR AU - Iorfida, M. AU - Maiorano, E. AU - Orvieto, E. AU - Maisonneuve, P. AU - Bottiglieri, L. AU - Rotmensz, N. PY - 2012 DA - 2012// TI - Invasive lobular breast cancer: subtypes and outcome JO - Breast Cancer Res Treat. VL - 133 UR - https://doi.org/10.1007/s10549-012-2002-z DO - 10.1007/s10549-012-2002-z ID - Iorfida2012 ER - TY - JOUR AU - Gonzalez-Angulo, A. M. AU - Sahin, A. AU - Krishnamurthy, S. AU - Yang, Y. AU - Kau, S. W. AU - Hortobagyi, G. N. PY - 2006 DA - 2006// TI - Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma JO - Clin Breast Cancer. VL - 7 UR - https://doi.org/10.3816/CBC.2006.n.056 DO - 10.3816/CBC.2006.n.056 ID - Gonzalez-Angulo2006 ER - TY - JOUR AU - Soussan, M. AU - Orlhac, F. AU - Boubaya, M. AU - Zelek, L. AU - Ziol, M. AU - Eder, V. PY - 2014 DA - 2014// TI - Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer JO - PLoS One. VL - 9 UR - https://doi.org/10.1371/journal.pone.0094017 DO - 10.1371/journal.pone.0094017 ID - Soussan2014 ER -